Callan Family Office Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.25M |
| 2 |
Blackstone
BX
|
+$4.64M |
| 3 |
Intuit
INTU
|
+$4.44M |
| 4 |
Cencora
COR
|
+$4.4M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$4.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$20M |
| 2 |
Apple
AAPL
|
+$19.1M |
| 3 |
NVIDIA
NVDA
|
+$18.1M |
| 4 |
Amazon
AMZN
|
+$14.7M |
| 5 |
Costco
COST
|
+$8.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Financials | 12.66% |
| 3 | Healthcare | 9.69% |
| 4 | Communication Services | 6.06% |
| 5 | Consumer Discretionary | 5.77% |
Similar funds
Callan Family Office's Q1 2025 Portfolio in Review
As of Q1 2025, Callan Family Office held 657 positions worth $1.33B, down 15% from $1.57B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Callan Family Office withdrew a net $202M in Q1 2025, closing 114 positions and reducing 341 holdings. Its most notable exit was iShares MSCI ACWI ex US ETF, an estimated $3.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Callan Family Office opened a new position in Berkshire Hathaway Class A worth $4.79M.
- Callan Family Office's largest Q1 2025 buy was Berkshire Hathaway Class A: 6 shares worth $4.79M.
- Callan Family Office added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $5.25M increase.
- Callan Family Office's biggest Q1 2025 reduction was Microsoft, cutting an estimated $20M.
- Callan Family Office fully exited iShares MSCI ACWI ex US ETF in Q1 2025, selling an estimated $3.63M.
- Callan Family Office's ten largest holdings make up 31% of its $1.33B portfolio in Q1 2025.
- Callan Family Office opened 30 new positions and closed 114 in Q1 2025.
- Callan Family Office's portfolio value fell 15% quarter-over-quarter to $1.33B.
Based on Callan Family Office's 13F filing for Q1 2025, filed 13 May 2025.